Evidence map›Paper›PMID 36036600›Full record

ArticleJournal of clinical microbiology2022

Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern.

Gabriel Diem, Eliott Lafon, Angelika Bauer, Cornelia Lass-Flörl, Markus Reindl, Doris Wilflingseder, Wilfried Posch

Abstract readLetter
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriel DiemInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Eliott LafonInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Angelika BauerClinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Cornelia Lass-FlörlInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-2946-7785
Markus ReindlClinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Doris WilflingsederInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-5888-5118
Wilfried PoschInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-8955-7654

Funding

Austrian Science Fund (FWF) P33510Austrian Science Fund (FWF) P34070Landes Tirols (Province of the Tyrol) 70454Oesterreichische Nationalbank (OeNB) P17614Oesterreichische Nationalbank (OeNB) P17633
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Antibodies, NeutralizingAntibodies, ViralHumansNeutralization TestsSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2mucosal immunityneutralizing antibodiessalivary IgASARS-CoV-2vaccinesvariants of concernvirus neutralization

Identifiers

PMID36036600
PMCPMC9491179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.